SCHEMBL21101836

SCHEMBL21101836

O=CCNC1(CO)CCCC1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.38
MME P08473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21101837 0.73 DPP4 (0.33) DPP4MME
SCHEMBL3428168 0.71 DPP4 (0.39) DPP4MME
SCHEMBL3428169 0.70 DPP4 (0.38) DPP4
SCHEMBL7902872 0.70 DPP4 (0.38) DPP4MME
SCHEMBL4296085 0.68 DPP4 (0.37) DPP4
SCHEMBL10289167 0.67 MME (0.37) DPP4MME
SCHEMBL4296090 0.67 DPP4 (0.36) DPP4MME
SCHEMBL20365908 0.67
SCHEMBL9781605 0.67
SCHEMBL8950833 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110589-A1 PYRROLO[2,3-B]PYRAZINE COMPOUNDS AS CCCDNA INHIBITORS FOR THE TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2019-06-13 WO disclosed